Home › Encyclopedia › GHRP-1: Research Status, Identity, and Trial Data
Research / Unapproved

GHRP-1: Research Status, Identity, and Trial Data

Molecular formulaC51H62N12O7
Molecular weight955.1 g/mol
Registered trials1
PubChem CID10350910

GHRP-1 is not approved by the FDA for any medical use, and no FDA label exists for this compound. Information available for it is limited to its chemical identity and a small footprint in registered clinical trials.

What GHRP-1 is

GHRP-1 is a synthetic peptide with the molecular formula C51H62N12O7 and a molecular weight of approximately 955.1 g/mol (PubChem CID 10350910). Because there is no approved label, no FDA-recognized drug class or mechanism of action statement is available for it.

Trial footprint

One clinical trial involving GHRP-1 is registered. That study, NCT00381602, was a Phase II, randomized, cross-over, vehicle-controlled, double-blind, multicenter trial examining safety, pharmacodynamics, and preliminary efficacy of GHRP-1/AG in subjects with end-stage renal disease on hemodialysis. The trial's status is listed as terminated.

FAQ

Is GHRP-1 FDA approved?
No. GHRP-1 has no FDA-approved label and is classified as an unapproved research compound. There are no approved indications, brand names, or official prescribing information for it.
What is GHRP-1 chemically?
GHRP-1 is a synthetic peptide with the molecular formula C51H62N12O7 and a molecular weight of about 955.1 g/mol. It is catalogued in PubChem under CID 10350910.
Has GHRP-1 been studied in clinical trials?
One registered clinical trial involving GHRP-1 exists. It was a Phase II, randomized, cross-over, vehicle-controlled, double-blind, multicenter study in subjects with end-stage renal disease on hemodialysis, and it was terminated.
What was the terminated GHRP-1 trial evaluating?
The trial, NCT00381602, examined safety, pharmacodynamics, and preliminary efficacy of GHRP-1/AG in people with end-stage renal disease undergoing hemodialysis. It did not proceed to completion, as its status is listed as terminated.
Are there known side effects reported for GHRP-1?
No adverse event report data are available for GHRP-1 in the sources reviewed. This reflects a lack of available data rather than a confirmed absence of side effects.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 10350910 ClinicalTrials.gov NCT00381602

Updated 2026-09-19